Yellow Wood Partners has announced the formation of a new sexual wellness platform, Beacon Wellness Brands, with the acquisition of several brands from Clio.
Beacon Wellness Brands markets and sells sexual wellness devices under the PlusOne and Deia brands. The company also has a personal care division and manufactures facial skin care and grooming products sold under the Plum Beauty and Clio brands.
Yellow Wood's diverse portfolio of beauty brands include Real Techniques and EcoTools, self-tanning brands Isle of Paradise, Tanologist and TanLuxe, and skin care brands Freeman Beauty and the recently launched Byoma.
Jennifer Roach Pacini, principal at Yellow Wood, said, "Sexual wellness has become a key pillar of personal wellness—alongside physical, nutritional, and emotional wellness. Consumers are increasingly thinking of sexual wellness as a sphere of their life integral to their holistic happiness and deserving of proactive focus. Sexual wellness is a high growth category supported by self-care trends and increasing consumer adoption, and PlusOne and Deia will help us launch Beacon as a broader sexual wellness platform. We look forward to leveraging the brand's leadership in retail to further expand distribution, launch new products and identify growth opportunities through acquisitions."
Jamie Leventhal, founder of Clio and who will continue to lead the Beacon Wellness Brands platform, said, "The sexual wellness category is evolving and becoming less taboo as consumers are increasingly more educated about their overall wellness and quality of life. Beacon Wellness is well positioned to capitalize on existing trends and from Yellow Wood's experience investing in global consumer brands and health-focused companies."
Tad Yanagi, partner at Yellow Wood, added, "We are excited to partner with Jamie and his team to further build out the Beacon Wellness platform in the emerging intimate wellness sector. The PlusOne brand has helped to institutionalize the sexual wellness category by making it approachable, affordable, and accessible to millions of consumers through drug and mass channels, becoming the No. 1 brand in the category."
